These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 14607721)

  • 1. Expression of cyclooxygenase-1 and -2 in extra-hepatic cholangiocarcinoma.
    Wu GS; Wang JH; Liu ZR; Zou SQ
    Hepatobiliary Pancreat Dis Int; 2002 Aug; 1(3):429-33. PubMed ID: 14607721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ERBB-2 overexpression and cyclooxygenase-2 up-regulation in human cholangiocarcinoma and risk conditions.
    Endo K; Yoon BI; Pairojkul C; Demetris AJ; Sirica AE
    Hepatology; 2002 Aug; 36(2):439-50. PubMed ID: 12143054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of cyclooxygenase-2 in cholangiocarcinoma: correlation with clinicopathological features and prognosis.
    Kim HJ; Lee KT; Kim EK; Sohn TS; Heo JS; Choi SH; Choi DI; Lee JK; Paik SW; Rhee JC
    J Gastroenterol Hepatol; 2004 May; 19(5):582-8. PubMed ID: 15086604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant cyclooxygenase isozyme expression in human intrahepatic cholangiocarcinoma.
    Chariyalertsak S; Sirikulchayanonta V; Mayer D; Kopp-Schneider A; Fürstenberger G; Marks F; Müller-Decker K
    Gut; 2001 Jan; 48(1):80-6. PubMed ID: 11115827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COX-2 inhibits Fas-mediated apoptosis in cholangiocarcinoma cells.
    Nzeako UC; Guicciardi ME; Yoon JH; Bronk SF; Gores GJ
    Hepatology; 2002 Mar; 35(3):552-9. PubMed ID: 11870367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated expression of cyclooxygenase-2 is a negative prognostic factor for overall survival in intrahepatic cholangiocarcinoma.
    Schmitz KJ; Lang H; Wohlschlaeger J; Reis H; Sotiropoulos GC; Schmid KW; Baba HA
    Virchows Arch; 2007 Feb; 450(2):135-41. PubMed ID: 17165088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of c-erbB-2 and cyclooxygenase-2 in intrahepatic cholangiocarcinoma.
    Choi HJ; Kim HJ; Choi JH
    Hepatogastroenterology; 2009; 56(91-92):606-9. PubMed ID: 19621664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different expression of cyclooxygenase-2 in biliary epithelia of bile duct cancer with or without pancreaticobiliary maljunction.
    Watanabe O; Yoshimatsu K; Shiozawa S; Tsuchiya A; Oshibe N; Aiba M; Ogawa K
    Anticancer Res; 2004; 24(2B):671-4. PubMed ID: 15161010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of c-erbB-2 proto-oncogene in extrahepatic cholangiocarcinoma and its clinical significance.
    Zheng J; Zhu YM
    Hepatobiliary Pancreat Dis Int; 2007 Aug; 6(4):412-5. PubMed ID: 17690040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of cyclooxygenase-2 (COX-2) in human bile duct epithelial cells and bile duct neoplasm.
    Hayashi N; Yamamoto H; Hiraoka N; Dono K; Ito Y; Okami J; Kondo M; Nagano H; Umeshita K; Sakon M; Matsuura N; Nakamori S; Monden M
    Hepatology; 2001 Oct; 34(4 Pt 1):638-50. PubMed ID: 11584358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclooxygenase-2 and ERBB-2 in cholangiocarcinoma: potential therapeutic targets.
    Sirica AE; Lai GH; Endo K; Zhang Z; Yoon BI
    Semin Liver Dis; 2002 Aug; 22(3):303-13. PubMed ID: 12360423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological significance of vascular endothelial growth factor-C and cyclooxygenase-2 in esophageal squamous cell carcinoma.
    Byeon JS; Jung HY; Lee YJ; Lee D; Lee GH; Myung SJ; Yang SK; Hong WS; Kim JH; Min YI; Kim JS
    J Gastroenterol Hepatol; 2004 Jun; 19(6):648-54. PubMed ID: 15151619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Akt expression may predict favorable prognosis in cholangiocarcinoma.
    Javle MM; Yu J; Khoury T; Chadha KS; Iyer RV; Foster J; Kuvshinoff BW; Gibbs JF; Geradts J; Black JD; Brattain MG
    J Gastroenterol Hepatol; 2006 Nov; 21(11):1744-51. PubMed ID: 16984600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of cyclooxygenase-2 in human hepatocellular carcinoma: relevance to tumor dedifferentiation.
    Koga H; Sakisaka S; Ohishi M; Kawaguchi T; Taniguchi E; Sasatomi K; Harada M; Kusaba T; Tanaka M; Kimura R; Nakashima Y; Nakashima O; Kojiro M; Kurohiji T; Sata M
    Hepatology; 1999 Mar; 29(3):688-96. PubMed ID: 10051469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metallothionein overexpression and its prognostic relevance in intrahepatic cholangiocarcinoma and extrahepatic hilar cholangiocarcinoma (Klatskin tumors).
    Schmitz KJ; Lang H; Kaiser G; Wohlschlaeger J; Sotiropoulos GC; Baba HA; Jasani B; Schmid KW
    Hum Pathol; 2009 Dec; 40(12):1706-14. PubMed ID: 19683330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of eicosanoid pathways in extrahepatic cholangiocarcinoma.
    Möbius C; Aust G; Wiedmann M; Wittekind C; Mössner J; Hauss J; Witzigmann H
    Anticancer Res; 2008; 28(2A):873-8. PubMed ID: 18507031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subepithelial myofibroblasts express cyclooxygenase-2 in colorectal tubular adenomas.
    Adegboyega PA; Ololade O; Saada J; Mifflin R; Di Mari JF; Powell DW
    Clin Cancer Res; 2004 Sep; 10(17):5870-9. PubMed ID: 15355919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The clinical significance of expression of cyclooxygenase-2 gene in breast cancer].
    Guo GL; Yao ZX; Wu J
    Zhonghua Yi Xue Za Zhi; 2003 Oct; 83(19):1661-4. PubMed ID: 14642098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of cyclooxygenase-2 and EP4 receptor in transitional cell carcinoma of the upper urinary tract.
    Miyata Y; Kanda S; Nomata K; Eguchi J; Kanetake H
    J Urol; 2005 Jan; 173(1):56-60. PubMed ID: 15592025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological correlates of aspartyl (asparaginyl) beta-hydroxylase over-expression in cholangiocarcinoma.
    Maeda T; Taguchi K; Aishima S; Shimada M; Hintz D; Larusso N; Gores G; Tsuneyoshi M; Sugimachi K; Wands JR; de la Monte SM
    Cancer Detect Prev; 2004; 28(5):313-8. PubMed ID: 15542253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.